Prof. Dr. Yılmaz ÖZYAZGAN | AVESİS

Akademik Veri Yönetim Sistemi

Yayınlar & Eserler

Makaleler 67

1. Mycophenolate mofetil may be an alternative for maintenance therapy of Behcet syndrome uveitis: a single-center retrospective analysis

UÇAR D., ESATOĞLU S. N., Cerme E., BATU OTO B., Hamuryudan V., SEYAHİ E., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.43, sa.11, ss.2099-2106, 2023 (SCI-Expanded)

2. Emergence of new manifestations during infliximab treatment in Behcet's syndrome

TÜKEK N. B., ESATOĞLU S. N., HATEMİ G., Caliskan E. B., Ozyazgan Y., UÇAR D., et al.

RHEUMATOLOGY , cilt.61, sa.9, ss.3746-3753, 2022 (SCI-Expanded)

3. Pediatric Uveitis in Turkey: The National Registry Report II

YALÇINDAĞ F. N., Ozdal P., Ozyazgan Y., Batioglu F., Tugal-Tutkun I.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.31, sa.10, ss.1971-1977, 2022 (SCI-Expanded)

4. Comparison of Sociodemographic Features Between Behcet Uveitis and Other Non-infectious Uveitis

YALÇINDAĞ F. N., Ozdal P. C., Ozyazgan Y., BATIOĞLU F., Tugal-Tutkun I.

TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY , cilt.51, sa.4, ss.206-211, 2021 (ESCI)

5. An Algorithm for the Diagnosis of Behcet Disease Uveitis in Adults

Tugal-Tutkun I., Onal S., Stanford M., AKMAN M., Twisk J. W. R., Boers M., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.29, sa.6, ss.1154-1163, 2021 (SCI-Expanded)

6. Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop

Agrawal R., Agarwal A., Jabs D. A., Kee A., Testi I., Mahajan S., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

7. Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study

Heissigerova J., Callanan D., de Smet M. D., Srivastava S. K., Karkanova M., Garcia-Garcia O., et al.

OPHTHALMOLOGY , cilt.126, sa.3, ss.428-437, 2019 (SCI-Expanded)

8. Clinical Characteristics of Older Age-Onset Behcet Syndrome Patients

Guzelant G., Ozyazgan Y., Mat C., Hamuryudan V., Yazici H., Seyahi E.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded)

9. Retrospective Analysis of Initial Presentation Findings of Behcet's Syndrome throughout 4 Decades

Dincses E., Ozguler Y., Ucar D., Ozyazgan Y., Ugurlu S., Hatemi G., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded)

10. Demographic and Clinical Characteristics of Uveitis in Turkey: The First National Registry Report

YALÇINDAĞ F. N., Ozdal P. C., Ozyazgan Y., BATIOĞLU F., Tugal-Tutkun I.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.26, sa.1, ss.17-26, 2018 (SCI-Expanded)

11. Temperament and Character Traits in Patients with Behcet's Disease with/without Eye Involvement

Ucar D., Yildirim Y., Gultekin G., Ozyazgan Y., Emul M.

SEMINARS IN OPHTHALMOLOGY , cilt.32, sa.2, ss.210-215, 2017 (SCI-Expanded)

12. Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study

Tugal-Tutkun I., KADAYIFÇILAR S., Khairallah M., Lee S. C., Ozdal P., Ozyazgan Y., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.25, sa.1, ss.62-70, 2017 (SCI-Expanded)

13. Novel Susceptible Genes for Behcet's Disease Identified By Dense Genotyping of Immune-Related Loci Implicate Host Responses to Microbial Exposure

Takeuchi M., Mizuki N., Meguro A., Ombrello M. J., Kirino Y., Satorius C., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

14. Ocular Involvement of Behcet's Syndrome: a Comprehensive Review

Ozyazgan Y., Ucar D., Hatemi G., Yazici Y.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY , cilt.49, sa.3, ss.298-306, 2015 (SCI-Expanded)

15. Evaluation of KIR3DL1/KIR3DS1 Association with Behcet's Disease in Turkish Individuals.

Erer B., Remmers E. F., Takeuchi M., Satorius C., Ustek D., Tugal-tutkun I., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded)

16. Interferon Alfa-Associated Depression in Patients with Behcet's Syndrome.

Keskin Y., Seyahi E., Poyraz C., Ugurlu S., Ozyazgan Y., Yazici H.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded)

17. Colchicine in Behcet Syndrome: A Longterm Survey of Patients in a Controlled Trial

Hamuryudan V., Hatemi G., Tascilar K., Yurdakul S., Mat C., Ozyazgan Y., et al.

JOURNAL OF RHEUMATOLOGY , cilt.41, sa.4, ss.735-738, 2014 (SCI-Expanded)

18. Identification of multiple genetic susceptibility loci for Behcet's disease

Takeuchi M., Mizuki N., Meguro A., Tugal-Tutkun I., Ozyazgan Y., Ohno S., et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE , cilt.55, sa.13, 2014 (SCI-Expanded)

19. An exceptional case of full-thickness macular hole closure in a patient with Behçet disease.

Ucar D., Atalay E., Ozyazgan Y., Ozkok A., Yildirim Y.

Ocular immunology and inflammation , cilt.22, sa.1, ss.79-81, 2014 (SCI-Expanded)

20. Behcet's syndrome: Facts and controversies

Mat C., Yurdakul S., Sevim A., Ozyazgan Y., Tuzun Y.

CLINICS IN DERMATOLOGY , cilt.31, sa.4, ss.352-361, 2013 (SCI-Expanded)

21. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease

Kirino Y., Zhou Q., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.110, sa.20, ss.8134-8139, 2013 (SCI-Expanded, Scopus)

22. **Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1**

Kirino Y., Bertsias G., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., et al.

NATURE GENETICS , cilt.45, sa.2, ss.202-207, 2013 (SCI-Expanded, Scopus)

23. Relation of Protein Oxidation Parameters and Disease Activity in Patients with Behcet's Disease

Ozyazgan S., Andican G., Erman H., Tuzcu A., Uzun H., Onal B., et al.

CLINICAL LABORATORY , cilt.59, ss.819-825, 2013 (SCI-Expanded)

24. Tear Nitric Oxide Levels in Behcet's Disease

Iscan Y., Yigit U., Tugcu B. C., Erdogan M., Erdogan D. A., Oner V., et al.

MEDICINA-LITHUANIA , cilt.48, sa.11, ss.559-562, 2012 (SCI-Expanded)

25. EYE DISEASE IN JUVENILE PATIENTS WITH BEHCET'S SYNDROME

Ozyazgan Y., Seyahi E., Sarica A., Ugurlu S., Hatemi G., Yurdakul S., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded)

26. COLCHICINE DOES NOT DECREASE THE NEED FOR IMMUNOSUPPRESSIVE USE AT LONG TERM IN BEHCET'S SYNDROME (BS)

Hamuryudan V., Hatemi G., Yurdakul S., Tascilar K., Mat C., Ozyazgan Y., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded)

27. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial

Hamuryudan V., Hatemi G., Tascilar K., Sut N., Ozyazgan Y., Seyahi E., et al.

RHEUMATOLOGY , cilt.49, sa.1, ss.173-177, 2010 (SCI-Expanded)

28. Ocular Involvement in Behcet's Disease

TURKDERM-ARCHIVES OF THE TURKISH DERMATOLOGY AND VENEROLOGY , cilt.43, ss.48-53, 2009 (SCI-Expanded)

29. Demographic and Clinical Features of Uveitis in Tertiary Centers in Turkey

Kazokoglu H., Onal S., Tugal-Tutkun I., Mirza E., Akova Y., Ozyazgan Y., et al.

OPHTHALMIC EPIDEMIOLOGY , cilt.15, sa.5, ss.285-293, 2008 (SCI-Expanded)

30. THE LONG TERM PROGNOSIS OF BEHCET'S SYNDROME AMONG MEN WITH SKIN-MUCOSA INVOLVEMENT AT ONSET: RE-EVALUATION OF A COHORT OF PATIENTS ENROLLED IN A CONTROLLED TRIAL

Hamuryudan V., Hatemi G., Tascilar K., Ozyazgan Y., Seyahi E., Mat C., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded)

31. Frequency of pathergy phenomenon and other features of Behcet's syndrome among patients with inflammatory bowel disease

Hatemi I., Hatemi G., Çelik A. B., Melikoglu M., Arzuhal N., Mat C., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded)

32. INFLIXIMAB IN 10 PATIENTS WITH BEHCET'S OCULAR INVOLVEMENT

Ozyazgan Y., Sarica A., Seyahi E., Hatemi G., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded)

33. A double-blind trial of depot corticosteroids in Behcet's syndrome

Mat C., Yurdakul S., Uysal S., Gogus F., Ozyazgan Y., Uysal O., et al.

RHEUMATOLOGY , cilt.45, sa.3, ss.348-352, 2006 (SCI-Expanded)

34. Short-term trial of etanercept in Behcet's disease: A double blind, placebo controlled study

Melikoglu M., Fresko I., Mat C., Ozyazgan Y., Gogus F., Yurdakul S., et al.

JOURNAL OF RHEUMATOLOGY , cilt.32, sa.1, ss.98-105, 2005 (SCI-Expanded)

35. Etanercept treatment in the endotoxin-induced uveitis of rats

Avunduk M., Avunduk A., Oztekin E., Baltaci A., Ozyazgan Y., Mogolkoc R.

EXPERIMENTAL EYE RESEARCH , cilt.79, sa.3, ss.357-365, 2004 (SCI-Expanded)

36. The long-term mortality and morbidity of Behcet syndrome - A 2-decade outcome survey of 387 patients followed at a dedicated center

Kural-Seyahi E., Fresko I., Seyahi N., Ozyazgan Y., Mat C., Hamuryudan V., et al.

MEDICINE , cilt.82, sa.1, ss.60-76, 2003 (SCI-Expanded)

37. Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: An open study

Hamuryudan V., Ozyazgan Y., Fresko Y., Mat C., Yurdakul S., Yazici H.

ISRAEL MEDICAL ASSOCIATION JOURNAL , cilt.4, sa.11, ss.928-930, 2002 (SCI-Expanded)

38. A double-blind trial of colchicine in Behcet's syndrome

Yurdakul S., Mat C., Tuzun Y., Ozyazgan Y., Hamuryudan V., Uysal O., et al.

ARTHRITIS AND RHEUMATISM , cilt.44, sa.11, ss.2686-2692, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

39. A reassessment of the International Study Group criteria for the diagnosis (classification) of Behcet's syndrome

Tunc R., Uluhan A., Melikoglu M., Ozyazgan Y., Ozdogan H. A., Yazici H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.19, sa.5, 2001 (SCI-Expanded)

40. Anti-MHC autoimmunity in Behcet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis

Kurhan-Yavuz S., Direskeneli H., Bozkurt N., Ozyazgan Y., Bavbek T., Kazokoglu H., et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY , cilt.120, sa.1, ss.162-166, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

41. Neutrophil chemotaxis in Behcet's syndrome

Tüzün B., Tuzun Y., Mat C., Yurdakul S., Hamuryudan V., Yazici H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.58, sa.10, ss.658, 1999 (SCI-Expanded)

42. Behcet's syndrome - The cerrahpasa experience

Yazici H., Fresko I., Hamuryudan V., Mat C., Melikoglu M., Ozyazgan Y., et al.

RHEUMADERM , cilt.455, ss.135-140, 1999 (SCI-Expanded)

43. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial

Hamuryudan V., Mat C., Saip S., Ozyazgan Y., Siva A., Yurdakul S., et al.

ANNALS OF INTERNAL MEDICINE , cilt.128, sa.6, ss.443-451, 1998 (SCI-Expanded)

44. Wound healing in Behcet's syndrome

Mat M. C., Nazarbaghi M., Tuzun Y., Hamuryudan V., Hızlı N., Yurdakul S., et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.37, sa.2, ss.120-123, 1998 (SCI-Expanded)

45. Azathioprine in Behcet's syndrome - Effects on long-term prognosis

Hamuryudan V., Ozyazgan Y., Hızlı N., Mat C., Yurdakul S., Tuzun Y., et al.

ARTHRITIS AND RHEUMATISM , cilt.40, sa.4, ss.769-774, 1997 (SCI-Expanded)

46. Treatment of Behcet disease with pentoxifylline

Hamuryudan V., Ozyazgan Y., Yazici H.

ANNALS OF INTERNAL MEDICINE , cilt.126, sa.6, ss.494, 1997 (SCI-Expanded)

47. FT.1991 -1996 yılları arasında penetran keratoplasti ameliyatlarımız ve sonuçları.

ASLAN O., İSKELELİ M. G., ÖZYAZGAN Y., DEVRANOĞLU K. K., ERMİŞ S., SAKALLI R., et al.

T.Oft.Gaz. , sa.26, ss.15-20, 1996 (Hakemli Dergi)

48. Epidemiology of Behcet's syndrome in Turkey

Tuzun Y., Yurdakul S., Ozyazgan Y., Hamuryudan V., Tuzun B., Yazici H.

INTERNATIONAL JOURNAL OF DERMATOLOGY , cilt.35, sa.9, ss.618-620, 1996 (SCI-Expanded)

49. Paterji pozitifliğinin pikür süresi ile ilişkisi

MAT M. C., GÖKLER G., YURDAKUL S., TÜZÜN Y., YAZICI H., HAMURYUDAN V., et al.

CERRAHPAŞA TIP DERGİSİ , cilt.27, ss.94-97, 1996 (Hakemli Dergi)

50. The ten-year mortality in Behcet's syndrome

Yazici H., Başaran G., Hamuryudan V., Hızlı N., Yurdakul S., Mat C., et al.

BRITISH JOURNAL OF RHEUMATOLOGY , cilt.35, sa.2, ss.139-141, 1996 (SCI-Expanded)

51. Akne Rozaseada oküler tutulum sıklığı

OĞUZ H., KARAÇORLU M., İSKELELİ M. G., ÖZYAZGAN Y., ERÇIKAN C., AYDEMİR E.

Cerrahpaşa Tıp Fak. Dergisi , sa.25, ss.223-225, 1994 (Hakemli Dergi)

52. SYSTEMIC INTERFERON-ALPHA-2B TREATMENT IN BEHCETS-SYNDROME

HAMURYUDAN V., Moral F., YURDAKUL S., MAT C., TUZUN Y., OZYAZGAN Y., et al.

JOURNAL OF RHEUMATOLOGY , cilt.21, sa.6, ss.1098-1100, 1994 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

53. Herpes simpleks virüsü (HSV) stroma keratiti geçirmiş olgularda kornea duyarlılığının aktif dönemdeki kornea duyarlılıklarıyla karşılaştırılması.

İSKELELİ M. G., Karaçorlu M., Özyazgan Y.

Cerrahpaşa Tıp Fak. Dergisi , ss.343-346, 1994 (Hakemli Dergi)

54. Behçet hastalığı

YAZICI H., YURDAKUL S., TÜZÜN Y., ÖZYAZGAN Y., MAT M. C., HAMURYUDAN V.

BİLİM VE TEKNİK , sa.314, ss.25-29, 1994 (Hakemli Dergi)

55. LOW-DOSE CYCLOSPORINE-A VERSUS PULSED CYCLOPHOSPHAMIDE IN BEHCETS-SYNDROME - A SINGLE MASKED TRIAL

OZYAZGAN Y., YURDAKUL S., YAZICI H., TUZUN B., ISCIMEN A., TUZUN Y., et al.

BRITISH JOURNAL OF OPHTHALMOLOGY , cilt.76, sa.4, ss.241-243, 1992 (SCI-Expanded)

56. A CONTROLLED TRIAL OF AZATHIOPRINE IN BEHCETS SYNDROME

YAZICI H., Pazarlı H., Barnes C. G., TUZUN Y., OZYAZGAN Y., Silman A., et al.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.322, sa.5, ss.281-285, 1990 (SCI-Expanded)

57. PROGNOSTIC VALUE OF HLA B5 ANTIGEN IN ISOLATED ANTERIOR UVEITIS IN BEHCETS-DISEASE

OGUZ V., Pazarlı H., OZYAZGAN Y., YAZICI H., YURDAKUL S., TUZUN Y., et al.

JOURNAL FRANCAIS D OPHTALMOLOGIE , cilt.12, ss.431-432, 1989 (SCI-Expanded)

58. THE PREVALENCE OF BEHCET SYNDROME IN A RURAL AREA IN NORTHERN TURKEY

YURDAKUL S., GÜNAYDIN İ., TUZUN Y., TANKURT N., Pazarlı H., OZYAZGAN Y., et al.

JOURNAL OF RHEUMATOLOGY , cilt.15, sa.5, ss.820-822, 1988 (SCI-Expanded)

59. Behçet hastalığı: Damar tutulmasının özellikleri

Müftüoğlu A., YURDAKUL S., YAZICI H., ÖZDOĞAN H., TÜZÜN Y., Pazarlı H., et al.

BAVS VAKIF GUREBA HASTANESİ DERGİSİ , cilt.12, ss.117-124, 1985 (Hakemli Dergi)

60. INFLUENCE OF AGE OF ONSET AND PATIENTS SEX ON THE PREVALENCE AND SEVERITY OF MANIFESTATIONS OF BEHCETS SYNDROME

YAZICI H., TUZUN Y., Pazarlı H., YURDAKUL S., OZYAZGAN Y., ÖZDOĞAN H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.43, sa.6, ss.783-789, 1984 (SCI-Expanded)

61. THE ARTHRITIS OF BEHCETS-DISEASE - A PROSPECTIVE-STUDY

YURDAKUL S., YAZICI H., TUZUN Y., Pazarlı H., YALCIN B., ALTAÇ M., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.42, sa.5, ss.505-515, 1983 (SCI-Expanded)

62. Kriyoglobulinemi: iki yöntemin kıyaslanması ve Behçet hastalığında kriyoglobulinler

ÖZBAKIR F., YAZICI H., ATAMAN N., Ülkü B. Y., Pazarlı H., TÜZÜN Y., et al.

CERRAHPAŞA TIP FAKÜLTESİ DERGİSİ , cilt.12, sa.4, ss.423-427, 1981 (Hakemli Dergi)

63. İki Yöntemin Kıyaslaması ve Behcet Hastalığında Kriyoglobulinler

ÖZBAKIR F., YAZICI H., Ataman U. K., Yalçın Ülkü P. B., Pazarlı P., Tüzün P. Y., et al.

Cerrahpaşa Tıp Fakültesi Dergisi , cilt.12, sa.3, ss.423-427, 1981 (Hakemli Dergi)

64. BEHCETS-DISEASE - LACK OF CORRELATION OF CLINICAL MANIFESTATIONS WITH HLA ANTIGENS

Müftüoğlu A., YAZICI H., YURDAKUL S., Pazarlı H., OZYAZGAN Y., TUZUN Y., et al.

TISSUE ANTIGENS , cilt.17, sa.2, ss.226-230, 1981 (SCI-Expanded)

65. USEFULNESS OF HLA DETERMINATION AND PATHERGY TEST IN THE DIAGNOSIS OF UVEITIS IN TURKEY

OZYAZGAN Y., Pazarlı H., YAZICI H., YURDAKUL S., TUZUN Y., ALTAÇ M., et al.

BRITISH JOURNAL OF OPHTHALMOLOGY , cilt.65, sa.11, ss.798-799, 1981 (SCI-Expanded)

66. Behçet Hastalığı: I. Hematolojik ve immunolojik özellikleri

Müftüoğlu A., Ülkü B. Y., EZER G., GÜRSOY A., YAZICI H., YURDAKUL S., et al.

CERRAHPAŞA TIP FAKÜLTESİ DERGİSİ , cilt.11, sa.3, ss.347-353, 1980 (Hakemli Dergi)

67. A DOUBLE-BLIND STUDY OF COLCHICINE IN BEHCETS DISEASE

AKTULGA E., ALTAÇ M., Müftüoğlu A., OZYAZGAN Y., Pazarlı H., TUZUN Y., et al.

HAEMATOLOGICA , cilt.65, sa.3, ss.399-402, 1980 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 14

1. Herpes simpleks virusü (HSV) stroma keratiti geçirmiş olgularda kornea duyarlılığının aktif dönemdeki kornea duyarlılıklarıyla karşılaştırılması

İSKELELİ M. G., KARAÇORLU M., ÖZYAZGAN Y.

TOD XXVII. Ulusal Kongre Bülteni,, Muğla, Türkiye, (Tam Metin Bildiri)

2. FACTORS ASSOCIATED WITH DAMAGE PROGRESSION IN BEHCET'S SYNDROME UVEITIS

Ozyazgan Y., Ucar D., Erdogan M., Ozguler Y., Hatemi G., Yurdakul S., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1187-1188, (Özet Bildiri)

3. BIOSIMILAR INFLIXIMAB FOR BEHCET'S SYNDROME: A CASE SERIES

Dincses E., Esatoglu S. N., Ozguler Y., Uygunoglu U., Hamuryudan V., Seyahi E., et al.

19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)

4. EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME

Guzelant G., Guzelant G., Ucar D., Hatemi G., Ozyazgan Y., Esatoglu S. N., et al.

18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.94, (Özet Bildiri)

5. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behcet's disease susceptibility

Takeuchi M., Mizuki N., Meguro A., Ombrello M., Tugal-tutkun I., Ozyazgan Y., et al.

Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), Washington, Amerika Birleşik Devletleri, 1 - 05 Mayıs 2016, cilt.57, (Özet Bildiri)

6. Antifosfolipid Sendrom Tanılı Hastada Retinal Bulgular ve Tedavisi

HEPOKUR M., UÇAR D., ÖZYAZGAN Y.

TOD 48. Ulusal Oftalmoloji Kongresi, Antalya, Türkiye, 5 - 09 Kasım 2014, ss.3, (Tam Metin Bildiri)

7. Üveititk Maküla Ödemi Olan Hastalarda Dekzametazon İntravitreal İmplant Sonuçlarımız

UÇAR D., DİKKAYA F., ÖZYAZGAN Y.

Türk Oftalmoloji Derneği 48. Ulusal Kongresi, Antalya, Türkiye, 5 - 09 Kasım 2014, ss.55, (Tam Metin Bildiri)

8. Göz Tutulumuna Göre Behçet Hastalarında Kisisel Özellikler ve Sosyal Durum

GÜLLÜ U., UÇAR D., ÖZYAZGAN Y., BATU B.

Türk Oftalmoloji Derneği 48. Ulusal Kongresi, Antalya, Türkiye, 5 - 09 Kasım 2014, ss.11, (Tam Metin Bildiri)

9. High Density Genotyping Of Immune-Related Disease Genes Identifies 7 New Susceptibility Loci For Behcets Disease

Takeuchi M., Mizuki N., Meguro A., Ombrello M. J., Satorius C., Kirino Y., et al.

77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

10. Infliximab For Sight-Threatening and Refractory Uveitis Of Behcet's Syndrome

Hamuryudan V., Hatemi G., Ozyazgan Y., Ucar D., Yurdakul S., Seyahi E., et al.

77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

11. Enfeksiyöz Olmayan Üveite Baglı Vaskülit ve Maküla Ödemi Tedavisinde 0.7 mg Deksametazon Intravitreal Implant Uygulamasının Kısa Dömen Sonuçları

ÖZYAZGAN Y., UÇAR D.

Türk Oftalmoloji Derneği 46. Ulusal Kongresi, Antalya, Türkiye, 17 - 21 Ekim 2012, ss.3

12. Behçet Hastalıgına Baglı Maküler Hole Spontan Kapanması

UÇAR D., ÖZYAZGAN Y., ATALAY E.

Türk Oftalmoloji Derneği 45. Ulusal Kongresi, Girne, Türkiye, 5 - 09 Ekim 2011, ss.11, (Tam Metin Bildiri)

13. ANTI-TNF THERAPY IN SEVERE UVEITIS OF BEHCET'S SYNDROME: REPORT OF 27 PATIENTS

Ugurlu S., Hamuryudan V., Ozyazgan Y., Seyahi E., Hatemi G., Yurdakul S., et al.

Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

14. COLCHICINE DOES NOT DECREASE THE NEED FOR IMMUNOSUPPRESSIVE USE AT LONG TERM IN BEHCET'S SYNDROME

Hamuryudan V., Hatemi G., Yurdakul S., Mat C., Tascilar K., Ozyazgan Y., et al.

Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

Kitaplar 1

1. Behçet's syndrome with emphasis on clinical genetics and mortality

YAZICI H., ÇİÇEK B., Başaran G., HAMURYUDAN V., ÇAKIR N., DIMITRIATRIS I., et al.

The Vasculitides, BM Ansell, PA Bacon, JT Lie, H. Yazici, Editör, Chapman & G.K. Hall & Co., London, ss.199-206, 1996

Metrikler

Yayın

82

Yayın (WoS)

66

Yayın (Scopus)

58

Atıf (WoS)

3995

H-İndeks (WoS)

26

Atıf (Scopus)

4309

H-İndeks (Scopus)

26

BM Sürdürülebilir Kalkınma Amaçları